79 related articles for article (PubMed ID: 10225537)
1. 5-methoxyindole metabolites of L-tryptophan: control of COX-2 expression, inflammation and tumorigenesis.
Wu KK; Cheng HH; Chang TC
J Biomed Sci; 2014 Mar; 21(1):17. PubMed ID: 24589238
[TBL] [Abstract][Full Text] [Related]
2. Highly pathogenic porcine reproductive and respiratory syndrome virus induces prostaglandin E2 production through cyclooxygenase 1, which is dependent on the ERK1/2-p-C/EBP-β pathway.
Bi Y; Guo XK; Zhao H; Gao L; Wang L; Tang J; Feng WH
J Virol; 2014 Mar; 88(5):2810-20. PubMed ID: 24352469
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib extends C. elegans lifespan via inhibition of insulin-like signaling but not cyclooxygenase-2 activity.
Ching TT; Chiang WC; Chen CS; Hsu AL
Aging Cell; 2011 Jun; 10(3):506-19. PubMed ID: 21348927
[TBL] [Abstract][Full Text] [Related]
4. Alpinia galanga extracts downregulate interleukin-1β-induced matrix metalloproteinases expression in human synovial fibroblasts.
Pothacharoen P; Choocheep K; Phitak T; Pompimon W; Kongtawelert P
In Vitro Cell Dev Biol Anim; 2011 Mar; 47(3):183-7. PubMed ID: 21132464
[TBL] [Abstract][Full Text] [Related]
5. S-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia.
Jakubowski A; Maksimovich N; Olszanecki R; Gebska A; Gasser H; Podesser BK; Hallström S; Chlopicki S
Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):281-90. PubMed ID: 18854985
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib as an in vivo probe of cyclooxygenase-2 mechanisms underlying retrograde amnesia in an animal model of ECT.
Andrade C; Thyagarajan S; Singh NM; Vinod PS; Sanjay Kumar Rao N; Chandra JS
J Neural Transm (Vienna); 2008 Jul; 115(7):1063-70. PubMed ID: 18523723
[TBL] [Abstract][Full Text] [Related]
7. n-3, n-6, and n-9 polyunsaturated fatty acids--which composition in parenteral nutrition decreases severity of acute hemorrhagic necrotizing pancreatitis in rats?
Kilian M; Heukamp I; Gregor JI; Bretthauer C; Walz MK; Jacobi CA; Lochs H; Schimke I; Guski H; Wenger FA
Int J Colorectal Dis; 2006 Jan; 21(1):57-63. PubMed ID: 15864609
[TBL] [Abstract][Full Text] [Related]
8. Effects of lornoxicam on the physiology of severe sepsis.
Memiş D; Karamanlioğlu B; Turan A; Koyuncu O; Pamukçu Z
Crit Care; 2004 Dec; 8(6):R474-82. PubMed ID: 15566594
[TBL] [Abstract][Full Text] [Related]
9. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
Hedner T; Samulesson O; Währborg P; Wadenvik H; Ung KA; Ekbom A
Drugs; 2004; 64(20):2315-43; discussion 2344-5. PubMed ID: 15456329
[TBL] [Abstract][Full Text] [Related]
10. Does cyclooxygenase-2 affect blood pressure?
Cheng HF; Harris RC
Curr Hypertens Rep; 2003 Feb; 5(1):87-92. PubMed ID: 12530941
[TBL] [Abstract][Full Text] [Related]
11. [Biological functions of cyclooxygenase 2: control of its expression and activity].
Jacquemin C
J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321
[TBL] [Abstract][Full Text] [Related]
12. COX-1 and COX-2 in health and disease.
Adelizzi RA
J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S7-12. PubMed ID: 10643175
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase 2: from inflammation to carcinogenesis.
Ristimäki A
Novartis Found Symp; 2004; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493
[TBL] [Abstract][Full Text] [Related]
14. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
15. Specific COX-2 inhibitors in arthritis, oncology, and beyond: where is the science headed?
Lipsky PE
J Rheumatol Suppl; 1999 Apr; 56():25-30. PubMed ID: 10225537
[TBL] [Abstract][Full Text] [Related]
16. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]